Adquate Mhlanga

Dr. Adquate Mhlanga

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2024 in The Lancet
Verified
Journal Article
Open access
AMAli H Mokdad
Ali H Mokdad
CBCatherine Bisignano
Catherine Bisignano
JHJohnathan M Hsu
Johnathan M Hsu
HAHazim S Ababneh
Hazim S Ababneh
RARouzbeh Abbasgholizadeh
Rouzbeh Abbasgholizadeh
CMChristopher J L Murray
Christopher J L Murray
The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 provides a comprehensive assessment of health and risk factor trends at global, regional, national, and subnational levels. This study aims to examine the burden of diseases, injuries, and risk factors in the USA and highlight the disparities in health outcomes across different states. GBD 2021 analysed trends in mortality, morbidity, and disability for 371 diseases and injuries and 88 risk factors in the USA between 1990 and 2021. We used several metrics to report sources of health and health loss related to specific diseases, injuries, and risk factors. GBD 2021 methods accounted for differences in data sources and biases. The analysis of levels and trends for causes and risk factors within the same computational framework enabled comparisons across states, years, age groups, and sex. GBD 2021 estimated years lived with disability (YLDs) and disability-adjusted life-years (DALYs; the sum of years of life lost to premature mortality and YLDs) for 371 diseases and injuries, years of life lost (YLLs) and mortality for 288 causes of death, and life expectancy and healthy life expectancy (HALE). We provided estimates for 88 risk factors in relation to 155 health outcomes for 631 risk-outcome pairs and produced risk-specific estimates of summary exposure value, relative health risk, population attributable fraction, and risk-attributable burden measured in DALYs and deaths. Estimates were produced by sex (male and female), age (25 age groups from birth to ≥95 years), and year (annually between 1990 and 2021). 95% uncertainty intervals (UIs) were generated for all final estimates as the 2·5th and 97·5th percentiles values of 500 draws (ie, 500 random samples from the estimate's distribution). Uncertainty was propagated at each step of the estimation process. We found disparities in health outcomes and risk factors across US states. Our analysis of GBD 2021 highlighted the relative decline in life expectancy and HALE compared with other countries, as well as the impact of COVID-19 during the first 2 years of the pandemic. We found a decline in the USA's ranking of life expectancy from 1990 to 2021: in 1990, the USA ranked 35th of 204 countries and territories for males and 19th for females, but dropped to 46th for males and 47th for females in 2021. When comparing life expectancy in the best-performing and worst-performing US states against all 203 other countries and territories (excluding the USA as a whole), Hawaii (the best-ranked state in 1990 and 2021) dropped from sixth-highest life expectancy in the world for males and fourth for females in 1990 to 28th for males and 22nd for females in 2021. The worst-ranked state in 2021 ranked 107th for males (Mississippi) and 99th for females (West Virginia). 14 US states lost life expectancy over the study period, with West Virginia experiencing the greatest loss (2·7 years between 1990 and 2021). HALE ranking declines were even greater; in 1990, the USA was ranked 42nd for males and 32nd for females but dropped to 69th for males and 76th for females in 2021. When comparing HALE in the best-performing and worst-performing US states against all 203 other countries and territories, Hawaii ranked 14th highest HALE for males and fifth for females in 1990, dropping to 39th for males and 34th for females in 2021. In 2021, West Virginia-the lowest-ranked state that year-ranked 141st for males and 137th for females. Nationally, age-standardised mortality rates declined between 1990 and 2021 for many leading causes of death, most notably for ischaemic heart disease (56·1% [95% UI 55·1-57·2] decline), lung cancer (41·9% [39·7-44·6]), and breast cancer (40·9% [38·7-43·7]). Over the same period, age-standardised mortality rates increased for other causes, particularly drug use disorders (878·0% [770·1-1015·5]), chronic kidney disease (158·3% [149·6-167·9]), and falls (89·7% [79·8-95·8]). We found substantial variation in mortality rates between states, with Hawaii having the lowest age-standardised mortality rate (433·2 per 100 000 [380·6-493·4]) in 2021 and Mississippi having the highest (867·5 per 100 000 [772·6-975·7]). Hawaii had the lowest age-standardised mortality rates throughout the study period, whereas Washington, DC, experienced the most improvement (a 40·7% decline [33·2-47·3]). Only six countries had age-standardised rates of YLDs higher than the USA in 2021: Afghanistan, Lesotho, Liberia, Mozambique, South Africa, and the Central African Republic, largely because the impact of musculoskeletal disorders, mental disorders, and substance use disorders on age-standardised disability rates in the USA is so large. At the state level, eight US states had higher age-standardised YLD rates than any country in the world: West Virginia, Kentucky, Oklahoma, Pennsylvania, New Mexico, Ohio, Tennessee, and Arizona. Low back pain was the leading cause of YLDs in the USA in 1990 and 2021, although the age-standardised rate declined by 7·9% (1·8-13·0) from 1990. Depressive disorders (56·0% increase [48·2-64·3]) and drug use disorders (287·6% [247·9-329·8]) were the second-leading and third-leading causes of age-standardised YLDs in 2021. For females, mental health disorders had the highest age-standardised YLD rate, with an increase of 59·8% (50·6-68·5) between 1990 and 2021. Hawaii had the lowest age-standardised rates of YLDs for all sexes combined (12 085·3 per 100 000 [9090·8-15 557·1]), whereas West Virginia had the highest (14 832·9 per 100 000 [11 226·9-18 882·5]). At the national level, the leading GBD Level 2 risk factors for death for all sexes combined in 2021 were high systolic blood pressure, high fasting plasma glucose, and...

30 October 2019 in Advances in Difference Equations
Verified
Journal Article
Open access
PDF file
AMAdquate Mhlanga
Adquate Mhlanga
Ebola virus disease (EVD) is a severe infection with an extremely high fatality rate spread through direct and indirect contacts. Recently, an outbreak of EVD in West Africa brought public attention to this deadly disease. We study the spread of EVD through a two-patch model. We determine the basic reproduction number, the disease-free equilibrium, two boundary equilibria and the endemic equilibrium when the disease persists in the two sub-populations for specific conditions. Further, we introduce time-dependent controls into our proposed model. We analyse the optimal control problem where the control system is a mathematical model for EVD that incorporates educational campaigns. The control functions represent educational campaigns in their respective patches, with one patch having more effective controls than the other. We aim to study how these control measures would be implemented for a certain time period, in order to reduce or eliminate EVD in the respective communities, while minimising the intervention implementation costs. Numerical simulations results are provided to illustrate the dynamics of the disease in the presence of controls.

11 July 2020 in Computational and Mathematical Methods in Medicine
Verified
Journal Article
Open access
PDF file
AMAdquate Mhlanga
Adquate Mhlanga
To better understand the dynamics of zoonotic diseases, we propose a deterministic mathematical model to study the dynamics of zoonotic brucellosis with a focus on developing countries. The model contains all the relevant biological details, including indirect transmission by the environment. We analyze the essential dynamic behavior of the model and perform an optimal control study to design effective prevention and intervention strategies. The sensitivity analysis of the model parameters is performed. The aim of the controls is tied to reducing the number of infected humans, through health promotional programs within the affected communities. The Pontryagin’s Maximum Principle is used to characterize the optimal level of the controls, and the resulting optimality system is solved numerically. Overall, the study demonstrates that through health promotional programs on zoonotic diseases among villagers, it is vital that they should be conducted with high efficacy.

1 July 2018 in Applied Mathematics and Nonlinear Sciences
Verified
Journal Article
Open access
PDF file
AMAdquate Mhlanga
Adquate Mhlanga
Herpes simplex virus (HSV-2) triples the risk of acquiring human immunodeficiency virus (HIV) and contributes to more than 50% of HIV infections in other parts of the world. A deterministic mathematical model for the co-interaction of HIV and HSV-2 in a community, with all the relevant biological detail and poor HSV-2 treatment adherence is proposed. The threshold parameters of the model are determined and stabilities are analysed. Further, we applied optimal control theory. We proved the existence of the optimal control and characterized the controls using Pontryagin’s maximum principle. The controls represent monitoring and counselling of individuals infected with HSV-2 only and the other represent monitoring and counselling of individuals dually infected with HIV and HSV-2. Numerical results suggests that more effort should be devoted to monitoring and counselling of individuals dually infected with HIV and HSV-2 as compared to those infected with HSV-2 only. Overall, the study demonstrate that, though time dependent controls will be effective on controlling HIV cases, they may not be sustainable for certain time intervals.

21 October 2022 in Mathematics
Verified
Journal Article
Open access
PDF file
AMAdquate Mhlanga
Adquate Mhlanga
RZRami Zakh
Rami Zakh
ACAlexander Churkin
Alexander Churkin
VRVladimir Reinharz
Vladimir Reinharz
JGJeffrey S. Glenn
Jeffrey S. Glenn
HDHarel Dahari
Harel Dahari
Hepatitis D virus is an infectious subviral agent that can only propagate in people infected with hepatitis B virus. In this study, we modified and further developed a recent model for early hepatitis D virus and hepatitis B virus kinetics to better reproduce hepatitis D virus and hepatitis B virus kinetics measured in infected patients during anti-hepatitis D virus treatment. The analytical solutions were provided to highlight the new features of the modified model. The improved model offered significantly better prospects for modeling hepatitis D virus and hepatitis B virus interactions.

19 November 2024 in Mathematics
Verified
Journal Article
Open access
PDF file
MHMlyashimbi Helikumi
Mlyashimbi Helikumi
TNThobias Bisaga Ntirukengwa
Thobias Bisaga Ntirukengwa
AKAncent Makau KIMULU
Ancent Makau KIMULU
AMAdquate Mhlanga
Adquate Mhlanga
In this research work, we developed a fractional-order model for the transmission dynamics of malaria, incorporating two control strategies: health education campaigns and the use of insecticides. The theoretical analysis of the model is presented, including the computation of disease-free equilibrium and basic reproduction number. We analyzed the stability of the proposed model using a well-formulated Lyapunov function. Furthermore, model parameter estimation was carried out using real data from malaria cases reported in Zimbabwe. We found that the fractional-order model provided a better fit to the real data compared to the classical integer-order model. Sensitivity analysis of the basic reproduction number was performed using computed partial rank correlation coefficients to assess the effect of each parameter on malaria transmission. Additionally, we conducted numerical simulations to evaluate the impact of memory effects on the spread of malaria. The simulation results indicated that the order of derivatives significantly influences the dynamics of malaria transmission. Moreover, we simulated the model to assess the effectiveness of the proposed control strategies. Overall, the interventions were found to have the potential to significantly reduce the spread of malaria within the population.